Skip to main content
Equibles

GEODE CAPITAL MANAGEMENT, LLC

Position in BTAIQ — BioXcel Therapeutics, Inc.

CIK 1214717 BOSTON, MA
Back to BTAIQ Full portfolio

Position in BTAIQ

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$341,573
+$33,148 QoQ
Shares Held
242,251
+5.2% QoQ
Ownership
0.774%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#5
of 47 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BTAIQ Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $4,788,152,578 across 66 Drug Manufacturers - Specialty & Generic names. BTAIQ ranks #47 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ZTS
Zoetis Inc.
 13,289,622 $954,992,236
2 UTHR
UNITED THERAPEUTICS Corp
 996,598 $539,986,694
3 VTRS
Viatris Inc
 32,807,906 $520,989,547
4 TEVA
Teva Pharmaceutical Industries Ltd
 11,607,196 $393,251,799
5 NBIX
Neurocrine Biosciences Inc
 2,138,777 $360,469,474
6 ELAN
Elanco Animal Health Inc
 11,302,057 $278,143,622
7 ALKS
Alkermes plc.
 4,477,876 $234,640,702
8 LNTH
Lantheus Holdings, Inc.
 1,841,367 $204,281,254

All Filings in BTAIQ

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $341,573 242,251
2026-03-31 $308,425 230,168
2025-12-31 $329,868 206,168
2025-09-30 $320,613 125,240
2025-06-30 $51,008 28,182
2025-03-31 $44,785 22,062
2024-12-31 — 311,965
2024-09-30 — 298,043
2024-06-30 — 266,719
2024-03-31 — 457,920
2023-12-31 — 450,227
2023-09-30 — 423,120
2023-06-30 — 404,650
2023-03-31 — 383,129
2022-12-31 — 374,999
2022-09-30 — 355,528
2022-06-30 — 343,698
2022-03-31 — 311,587
2021-12-31 — 301,297
2021-09-30 — 297,039
2021-06-30 — 276,819
2021-03-31 — 252,640
2020-12-31 — 224,237
2020-09-30 — 206,154
2020-06-30 — 161,384
2020-03-31 — 135,579